Recent Added Health Technologies

• Loxapine inhalation for agitation associated with schizophrenia or bipolar disorder
• Afatinib for advanced and/or metastatic non-small cell lung cancer (NSCLC) with EGFR mutation
• Apixaban for stroke prevention in atrial fibrillation
• Axitinib for advanced and/or metastatic renal cell carcinoma – second line.
• Bevacizumab with trastuzumab and docetaxel for metastatic HER2 positive breast cancer
• Oral calcitonin for osteoarthritis (OA) of the knee in men and postmenopausal women – first line
• Vorapaxar for acute coronary syndrome
• Erlotinib hydrochloride (Tarceva) for advanced non-small cell lung cancer with activating mutations
• OncoVEX GM-CSF for unresectable metastatic melanoma – first and second line treatment
• Taspoglutide for type 2 diabetes mellitus